[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fGnfamzdAxJZAYsihiQSo6isQ4JtbaNDCf3pUffRlCcY":8,"$fqcbKleDZ6yIJe9Pawllw5OQJquvm2rCMgiSWhUASU6g":55,"$fmBACYaZiyOPllALN0SeRRfpiWiDjRWsz3Jt7iZ7Jdto":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},50717,869732,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//qvhCCTIvcNBh6P1V3cjuUDfxcVOObxse.png","杨丰名","浙江大学医学院附属第二医院","肿瘤科","主治医师",41,0,"结肠恶性肿瘤相关常用药品安全用药指南","","https://ystcdn.venuertc.com/venue/AI/976731b4-7452-44e6-a646-efe4cd3630bf.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结肠恶性肿瘤相关常用药品安全用药指南\u003C/h1>\n  \u003Cdiv class=\"drug-guide-intro\">\n    日常化疗、靶向治疗、支持用药等环节，药品的使用细节决定着安全性和效果。以阿瑞匹坦、甲氧氯普胺、昂丹司琼、伊立替康、贝伐珠单抗等结肠恶性肿瘤治疗常见药物为例，本指南将围绕六大核心用药要点，为您详细解析正确使用方法、注意事项、常见风险及应对方式。每一步都关系着治疗顺利进行，值得认真了解和掌握。\n  \u003C/div>\n\n  \u003C!-- 药品作用机制简介 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #f0f7fa 0%, #e8f0fe 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 常用药品作用机制一览 🔬\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>止吐药物（阿瑞匹坦、甲氧氯普胺、昂丹司琼）：\u003C/strong>\n          通过阻断特定神经递质通路（如5-HT\u003Csub>3\u003C/sub>受体和NK1受体），减少化疗引起的呕吐信号传递，保护消化系统舒适。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物（伊立替康）：\u003C/strong>\n          抑制细胞DNA的复制与修复，阻止肿瘤细胞生长。这是一把精准打击异常细胞的“剪刀”。\u003Cspan class=\"drug-guide-emoji\">✂️\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>贝伐珠单抗：\u003C/strong>\n          属于靶向药，可抑制肿瘤生长所需的新生血管生成，为肿瘤“断供”，削弱其扩展能力。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助和支持药物：\u003C/strong>\n          如亚叶酸钙参与增强化疗敏感性，地塞米松抗炎，硫酸阿托品解痉缓解药物副作用，粒细胞刺激因子（如聚乙二醇化重组人粒细胞刺激因子）提升白细胞数量以减轻骨髓抑制。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>生血宝合剂：\u003C/strong>\n          中成药成分，多用于辅助补血调理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"drug-guide-note\">\n        \u003Cspan class=\"drug-guide-emoji\">📖\u003C/span>\n        内容参考：Hurwitz, H. et al. (2004). \"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.\" The New England Journal of Medicine, 350(23), 2335-2342.\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 剂型与服药技巧 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #fdf6e3 0%, #f2efe1 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型特点与实际用药操作 🍶\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>口服剂型：\u003C/strong>\n          如阿瑞匹坦胶囊和生血宝合剂。服用时应注意整粒吞服或按说明计量，一般建议用足量清水送服，不能自行剪开或嚼碎胶囊。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射剂型：\u003C/strong>\n          包括静脉推注、静滴、肌肉/皮下注射等。所有注射药物（如伊立替康、贝伐珠单抗、粒细胞刺激因子等）必须由专业医务人员操作，严格按照剂量和速度防止过敏及不良反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>特殊剂型：\u003C/strong>\n          地塞米松磷酸钠多为注射液，部分止吐药（如昂丹司琼）有口服、注射两种形式。选用时须参照医嘱及药品指导。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips\">\n        \u003Cspan class=\"drug-guide-emoji\">💡\u003C/span>\n        服药前务必核查标签，尤其类似名称药品，防止拿错。混悬剂如生血宝应充分摇匀。\n      \u003C/div>\n      \u003Cdiv class=\"drug-guide-case\">\n        案例：有位患者因误将注射用药口服，造成不适，最后在医护及时发现后妥善处理。提醒大家：剂型不对等于吃错药！\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 服用时间与方法 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #f5e8ff 0%, #f8f6fb 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 服用与给药时间安排 🕒\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>止吐药（如阿瑞匹坦、昂丹司琼）：\u003C/strong>\n          常需在化疗药物给药前30-60分钟服用，充分发挥预防作用。这类药物通常有详细的时间要求，切勿自行提前或延后。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物（伊立替康、贝伐珠单抗等）：\u003C/strong>\n          按医生制定的疗程、周期用药。每次用药前需评估血常规等指标，确保用药安全。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药物与支持治疗：\u003C/strong>\n          如地塞米松和亚叶酸钙，既可并用也可分开，根据医嘱安排具体顺序和时间。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>生血宝合剂：\u003C/strong>\n          建议每日定时服用，养成习惯可提高遵医行为促进疗效。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-case\">\n        临床常见：有老年患者因忘记服用止吐药，导致用药后恶心明显增加。为避免遗忘，可以把服药时间和活动安排结合起来，比如饭前/饭后定点服用。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 药物相互作用 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #f0faef 0%, #e8f8e8 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物间相互作用 ⚖️\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>阿瑞匹坦：\u003C/strong>\n          可与多种药物代谢酶相互作用（尤其是CYP3A4相关药物，如某些抗真菌药、降脂药），合用可能影响疗效或毒性。务必同步告知医生全部用药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>贝伐珠单抗：\u003C/strong>\n          与其他抑制血管生成或影响凝血功能的药物（如某些NSAIDs）合用时有出血风险，要格外警惕。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>甲氧氯普胺：\u003C/strong>\n          与抗精神病、镇静睡眠类药物一起用，有增加锥体外系反应的危险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>亚叶酸钙与化疗药物：\u003C/strong>\n          不同化疗方案搭配剂量和时间需严守医嘱，随意更改顺序可影响药效并增加毒副作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>补充：\u003C/strong>\n          生血宝合剂与西药配用一般安全，但特殊情况建议分开1-2小时服用，减少消化道刺激和反应。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"drug-guide-note\">\n        \u003Cspan class=\"drug-guide-emoji\">📑\u003C/span>\n        临床研究显示，合理的药物组合管理可有效降低药物不良反应发生率（Seyfried, M.E. et al., 2009, Clinical Colorectal Cancer, 8(3):186-194）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药注意事项与特殊人群 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #eaf4fc 10%, #f5fafd 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药注意事项与特殊人群指导 👵👴\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>\n          代谢能力下降，需要适当调整化疗药物及辅助药品剂量。观察不良反应尤为重要，如有异常身感应及时联系医生。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能减弱：\u003C/strong>\n          部分化疗药（如伊立替康）或需减量或间隔延长，频繁监测肝肾功能。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇及哺乳期女性：\u003C/strong>\n          多数化疗和部分辅助药物禁用于孕期、哺乳期。具体应由医生评估权衡利弊。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药物过敏史：\u003C/strong>\n          对药品或成分有已知过敏史时，务必提前申报，全程监控用药反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>患有其他基础病：\u003C/strong>\n          心血管、内分泌等慢性病患者须与主治医生沟通综合用药方案。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-case\">\n        一位71岁男性患者在使用多种药品（包括化疗、止吐、辅助药）后，因严密监控未出现严重不良反应。可见个体化调整和监测非常关键。\n      \u003C/div>\n      \u003Cp class=\"drug-guide-tips\">\n        \u003Cspan class=\"drug-guide-emoji\">📝\u003C/span>\n        没有任何药物可以“一刀切”长期使用，特殊人群更要主动配合医生调整方案。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 常见不良反应及处理 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #f9f1e9 10%, #fff6ec 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与应对方法 🛑\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>止吐药：\u003C/strong>\n          常见副作用包括头痛、便秘、嗜睡（如昂丹司琼、阿瑞匹坦）；部分人可有急性过敏反应。如果药后出现皮疹、呼吸困难等，应立即就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>伊立替康：\u003C/strong>\n          可能引起腹泻、白细胞减少等，早期反应多可通过硫酸阿托品等辅助药物处理。若出现高热、腹泻不停需紧急处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>贝伐珠单抗：\u003C/strong>\n          偶见高血压、蛋白尿、出血倾向。服药期间要规律监测血压、尿常规，并注意牙龈和鼻腔等部位出血迹象。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>地塞米松：\u003C/strong>\n          长期或大剂量使用可能导致消化道反应、情绪波动等。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>粒细胞刺激因子：\u003C/strong>\n          重点监控注射部位肿胀和骨关节酸痛。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>生血宝合剂：\u003C/strong>\n          轻度胃肠不适较常见，个别人可能腹泻、恶心。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv>\n        正确做法：遇到副作用不慌乱，遵医指导调整剂量或变更药物。如出现严重过敏、持续高热或出血立刻就医。\n      \u003C/div>\n      \u003Cp class=\"drug-guide-note\">\n        \u003Cspan class=\"drug-guide-emoji\">🔎\u003C/span>\n        数据表明，贝伐珠单抗常见副作用（如高血压发生率可达8-20%）（Kabbinavar, F. F. et al., 2005, The Oncologist, 10(5): 373-379）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 储存和过期药品处理 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #e7fbe9 0%, #f5fefa 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存与过量/漏服处理 📦\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>储存条件：\u003C/strong>\n          绝大多数口服和注射药品应放置在阴凉、干燥处，避免高温。开封后的小瓶剂药物尽量≤7天用完。部分注射剂需冷藏2-8℃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>有效期管理：\u003C/strong>\n          超过有效期的药品不得继续使用。弃置时严防儿童误服。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药品包装：\u003C/strong>\n          记得每次使用前查看瓶装、批号和药品状态。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>漏服/过量：\u003C/strong>\n          漏服口服药物：想起后尽快补服，但下次服药时间临近则跳过，不得自行加量。注射药物如漏用需联系医生安排补充。过量用药应立即就医，保留药品包装便于医生处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv>\n        正确做法：药品定点归置，瓶贴日期，每周定期自查剩余量。出现用药记录混乱，咨询医务人员梳理清楚才能用得安心。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 总结归纳 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: linear-gradient(120deg, #f9fafe 10%, #fef0f5 100%);\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">最值得记住的用药安全要点 🌟\u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          药品作用各有专项，不要混淆类别与用途，必须按说明或医嘱分别正确使用。\n        \u003C/li>\n        \u003Cli>\n          服药时间、剂量、搭配、用药顺序须严格把关，特殊人群尤其需个体调整。\n        \u003C/li>\n        \u003Cli>\n          药品储存、过期与误服都不容忽视，定期检查保证安全。\n        \u003C/li>\n        \u003Cli>\n          出现疑问、异常反应应妥善记录并及时寻求专业医疗支持。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        用药如同细致的生活管理，用心做好每一步，是获得最佳效果和避开风险的关键。合理用药，让治疗更安心。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"drug-guide-section\" style=\"background: #fffbfb;\">\n    \u003Ch2 class=\"drug-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cul class=\"drug-guide-ref\">\n      \u003Cli>\n        Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., ... & Kabbinavar, F. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Cem>The New England Journal of Medicine\u003C/em>, 350(23), 2335-2342.\n      \u003C/li>\n      \u003Cli>\n        Seyfried, M. E., Dickens, A. M., Mican, J. M., & Rothwell, R. S. (2009). Management of combination chemotherapy toxicities. \u003Cem>Clinical Colorectal Cancer\u003C/em>, 8(3), 186-194.\n      \u003C/li>\n      \u003Cli>\n        Kabbinavar, F. F., Hambleton, J., Mass, R. D., Hurwitz, H. I., Bergsland, E., & Sarkar, S. (2005). Combined analysis of efficacy: The Oncologist, 10(5), 373-379.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-container {\n  max-width: 880px;\n  margin: 26px auto;\n  padding: 32px 22px 32px 22px;\n  background: #f8fafd;\n  border-radius: 17px;\n  box-shadow: 0 6px 18px rgba(92, 166, 200, 0.08), 0 2px 8px rgba(120, 140, 150, 0.07);\n  font-family: 'Segoe UI', 'PingFang SC', Arial, sans-serif;\n  color: #223344;\n}\n.drug-guide-title {\n  font-size: 2.3em;\n  font-weight: bold;\n  color: #253857;\n  margin-bottom: 22px;\n  letter-spacing: 0.04em;\n  text-align: left;\n}\n.drug-guide-intro {\n  font-size: 1.18em;\n  line-height: 1.9;\n  margin-bottom: 35px;\n  background: #ecf3fa;\n  border-left: 5px solid #54b5ee;\n  padding: 20px 18px 20px 20px;\n  border-radius: 9px;\n}\n.drug-guide-section {\n  margin-bottom: 38px;\n  border-radius: 14px;\n  padding: 28px 22px 22px 22px;\n  box-shadow: 0 2px 8px rgba(190, 205, 215, 0.07);\n}\n.drug-guide-section-title {\n  font-size: 1.42em;\n  font-weight: 600;\n  color: #295698;\n  margin-bottom: 10px;\n  letter-spacing: 0.03em;\n}\n.drug-guide-section-content {\n  font-size: 1.1em;\n  color: #34414f;\n  line-height: 1.9;\n  padding-left: 4px;\n}\n.drug-guide-section-content ul {\n  list-style: disc;\n  padding-left: 24px;\n  margin: 0 0 10px 0;\n}\n.drug-guide-section-content li {\n  margin-bottom: 6px;\n}\n.drug-guide-tips {\n  background: #fff3d4;\n  color: #675534;\n  border-left: 4px solid #ffc770;\n  border-radius: 7px;\n  padding: 12px 14px;\n  font-size: 1em;\n  margin: 14px 0 8px 0;\n  display: flex;\n  align-items: center;\n}\n.drug-guide-case {\n  border-left: 4px solid #b3e8f7;\n  padding: 11px 14px;\n  background: #f8fcfe;\n  color: #266181;\n  border-radius: 7px;\n  margin-bottom: 10px;\n  font-size: 1em;\n}\n.drug-guide-note {\n  background: #f1f7fd;\n  color: #535e79;\n  border-left: 3px solid #6ca8ed;\n  padding: 10px 14px;\n  border-radius: 6px;\n  margin-top: 12px;\n  font-size: 0.96em;\n  line-height: 1.7;\n}\n.drug-guide-emoji {\n  font-size: 1.22em;\n  margin-right: 4px;\n}\n.drug-guide-ref {\n  font-size: 1em;\n  line-height: 1.5;\n  padding-left: 20px;\n  color: #707c8a;\n}\n.drug-guide-ref li {\n  margin-bottom: 7px;\n}\n@media screen and (max-width: 550px) {\n  .drug-guide-container {\n    padding: 9px 3% 18px 3%;\n  }\n  .drug-guide-section {\n    padding: 13px 6px 13px 12px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\" style=\"color: ",549,"2025-07-21 11:52:05","结肠恶性肿瘤, 药品使用, 安全用药, 化疗药物, 靶向治疗, 不良反应, 患者指导, 治疗安全","了解结肠恶性肿瘤常用药品的正确使用方法与注意事项，保障治疗安全与效果，帮助患者及家属应对常见风险问题。","2025-07-21 18:24:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]